|
May 10
|
EDAP TMS S.A.'s (NASDAQ:EDAP) top owners are individual investors with 56% stake, while 24% is held by institutions
|
|
May 6
|
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
|
|
May 2
|
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
|
|
Apr 23
|
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
|
|
Mar 30
|
EDAP TMS S.A. (NASDAQ:EDAP) Just Reported Earnings, And Analysts Cut Their Target Price
|
|
Mar 29
|
EDAP TMS S.A. (NASDAQ:EDAP) Q4 2023 Earnings Call Transcript
|
|
Mar 27
|
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
|
|
Mar 13
|
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
|
|
Mar 6
|
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
|
|
Mar 4
|
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
|
|
Feb 1
|
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
|
|
Dec 6
|
EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
|
|
Nov 30
|
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
|
|
Nov 10
|
EDAP TMS S.A. (NASDAQ:EDAP) Q3 2023 Earnings Call Transcript
|
|
Nov 9
|
EDAP Announces Third Quarter 2023 Financial Results
|
|
Nov 6
|
EDAP to Present at the Jefferies London Healthcare Conference
|
|
Aug 10
|
EDAP TMS SA to Announce Second Quarter 2023 Financial Results on August 24, 2023
|